|

Omalizumab Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Xolair

Pipeline

Phase 2: 2

Top Sponsors

  • Longbio Pharma1
  • Children's National Research Institute1
  • Celltrion HealthCare France1

Indications

  • Asthma3
  • Allergic Asthma2
  • Viral Upper Respiratory Infection1
  • Atopy1
  • Asthma in Children1

Other2 trials

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Phase 2
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Washington D.C., District of Columbia1 trial

Omalizumab Before Onset of Exacerbations

Children's National Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.